Breast Neoplasms

"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the human BREAST.

Descriptor ID	D001943
MeSH Number(s)	C04.588.180 C17.800.090.500
Concept/Terms	Breast Neoplasms Breast Neoplasms Breast Neoplasm Neoplasm, Breast Breast Tumors Breast Tumor Tumor, Breast Tumors, Breast Neoplasms, Breast Breast Carcinoma Breast Carcinoma Breast Carcinomas Carcinoma, Breast Carcinomas, Breast Mammary Neoplasms, Human Mammary Neoplasms, Human Human Mammary Neoplasm Human Mammary Neoplasms Neoplasm, Human Mammary Neoplasms, Human Mammary Mammary Neoplasm, Human Breast Cancer Breast Cancer Cancer, Breast Mammary Cancer Cancer, Mammary Cancers, Mammary Mammary Cancers Malignant Neoplasm of Breast Breast Malignant Neoplasm Breast Malignant Neoplasms Malignant Tumor of Breast Breast Malignant Tumor Breast Malignant Tumors Cancer of Breast Cancer of the Breast

Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Breast Neoplasms [C04.588.180]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Breast Diseases [C17.800.090]
Breast Neoplasms [C17.800.090.500]

Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.

Bar chart showing 1969 publications over 31 distinct years, with a maximum of 129 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	10	5	15
1996	18	1	19
1997	19	4	23
1998	19	3	22
1999	32	5	37
2000	34	9	43
2001	24	7	31
2002	51	12	63
2003	73	13	86
2004	71	9	80
2005	86	9	95
2006	77	7	84
2007	94	5	99
2008	94	13	107
2009	97	11	108
2010	119	10	129
2011	103	8	111
2012	77	11	88
2013	59	14	73
2014	68	7	75
2015	59	7	66
2016	69	5	74
2017	57	3	60
2018	63	4	67
2019	50	4	54
2020	48	1	49
2021	67	0	67
2022	64	1	65
2023	38	0	38
2024	34	4	38
2025	2	1	3

Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.

Alam R, Reva A, Edwards DG, Lege BM, Munoz-Arcos LS, Reduzzi C, Singh S, Hao X, Wu YH, Tian Z, Natalee LM, Damle G, Demircioglu D, Wang Y, Wu L, Molteni E, Hasson D, Lim B, Gugala Z, Chipuk JE, Lang JE, Sparano JA, Cheng C, Cristofanilli M, Xiao H, Zhang XH, Bado IL. Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast Cancer. Cancer Discov. 2025 Apr 02; 15(4):818-837.

View in: PubMed
Podany EL, Foffano L, Gerratana L, Medford AJ, Clifton K, Tapiavala S, Velimirovic M, Lipsyc-Sharf M, Reduzzi C, Bubie A, Putur A, Ademuyiwa FO, Puglisi F, Gradishar WJ, Ma CX, Bardia A, Cristofanilli M, Davis AA. Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer. JAMA Netw Open. 2025 Feb 03; 8(2):e2461899.

View in: PubMed
Bakillah E, Brooks AD, Adekeye S. Switching to Tumescent Dissection in Mastectomy. Breast J. 2025; 2025:7634729.

View in: PubMed
Leslie Salewon M, Pathak R, Dooley WC, Squires RA, Rui H, Chervoneva I, Tanaka T. Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.

View in: PubMed
Kamaraju S, Fowler AM, Tarima S, Chaudhary LN, Burkard ME, Giever T, Cheng YC, Parkes A, Lange CA, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns JM, Rui H, Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K. A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer. Clin Breast Cancer. 2025 Apr; 25(3):251-260.

View in: PubMed
Ahluwalia VS, Doiphode N, Mankowski WC, Cohen EA, Pati S, Pantalone L, Bakas S, Brooks A, Vachon CM, Conant EF, Gastounioti A, Kontos D. Volumetric Breast Density Estimation From Three-Dimensional Reconstructed Digital Breast Tomosynthesis Images Using Deep Learning. JCO Clin Cancer Inform. 2024 Dec; 8:e2400103.

View in: PubMed
Singh P, Agnese DM, Amin M, Barrio AV, van den Bruele AB, Burke EE, Danforth DN, Dirbas FM, Eladoumikdachi F, Fayanju OM, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Woodfin A, Laronga C, Boughey JC. Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks. Ann Surg Oncol. 2025 Feb; 32(2):899-911.

View in: PubMed
Montagna G, Laws A, Ferrucci M, Mrdutt MM, Sun SX, Bademler S, Balbaloglu H, Balint-Lahat N, Banys-Paluchowski M, Barrio AV, Benson J, Bese N, Boughey JC, Boyle MK, Diego EJ, Eden C, Eller R, Goldschmidt M, Hlavin C, Heidinger M, Jelinska J, Karadeniz Cakmak G, Kesmodel SB, King TA, Kuerer HM, Loesch J, Milardi F, Murawa D, Moo TA, Menes TS, Passeri D, Pastoriza JM, Perhavec A, Pislar N, Polidorio N, Rami A, Ryu JM, Schulz A, Sevilimedu V, Ugurlu MU, Uras C, van Hemert A, Wong SM, Yoo TR, Zhang JQ, Karanlik H, Cabioglu N, Peeters MV, Morrow M, Weber WP. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study. J Clin Oncol. 2025 Mar; 43(7):810-820.

View in: PubMed
Barrio AV, Morrow M, Mehrara BJ. Social Work's Role in Bridging Breast Cancer Care Gaps-Reply. JAMA Surg. 2024 Oct 01; 159(10):1221-1222.

View in: PubMed
Fine RE, Gilmore RC, Tomkovich KR, Dietz JR, Berry MP, Hernandez LE, Columbus KS, Seedman SA, Fisher CS, Han LK, Manahan ER, Hicks RD, Vaidya RP, Curcio LD, Sevrukov AB, Kenler AS, Taback B, Chen M, Miller ME, Gold L, Anglin BV, Aoun HD, Simmons RM, Feldman SM, Boolbol SK. Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence. Ann Surg Oncol. 2024 Oct; 31(11):7273-7283.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement